Sangoma Reports Q3 Loss, Cuts FY26 Guidance, Initiates Strategic Review
SANG is trading near its 52-week low of $3.71 (10% above the low).
Summary
Sangoma Technologies reported a wider net loss and lower revenue for Q3 fiscal 2026, leading to a downward revision of its full-year guidance. The company also announced a strategic review to evaluate options for maximizing shareholder value.
Key Events · Corporate Governance and Compliance · SANG
-
Q3 Fiscal 2026 Financial Performance
Revenue decreased 12% year-over-year to $51.0 million. Net loss widened to $2.3 million from $1.4 million in the prior year, and Adjusted EBITDA fell 24% to $7.5 million.
-
Fiscal 2026 Guidance Revision
The company lowered its full-year fiscal 2026 revenue guidance from $205-$208 million to $204-$205 million, and Adjusted EBITDA margin guidance from 17-18% to 15-16%.
-
Strategic Review Initiated
The Board of Directors has engaged ATB Cormark Capital Markets to evaluate strategic alternatives, including partnerships, business combinations, and investments, to maximize shareholder value.
-
Debt Reduction and NCIB Renewal
Total debt was reduced by 39% year-over-year to $32.5 million. The company also renewed its Normal Course Issuer Bid to repurchase up to 5% of outstanding shares.
Analysis · SANG · Technology
Sangoma Technologies reported a significant decline in its third-quarter financial performance, with revenue falling and net loss increasing. This led the company to lower its full-year fiscal 2026 revenue and Adjusted EBITDA guidance, signaling a weaker outlook. Concurrently, the Board of Directors announced a strategic review to explore options such as partnerships, business combinations, or investments, aiming to maximize shareholder value. This suggests the company is considering major structural or ownership changes in response to market dynamics and performance.
At the time of this filing, SANG was trading at $4.09 on NASDAQ in the Technology sector, with a market capitalization of approximately $135.9M. The 52-week trading range was $3.71 to $6.49. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.